Literature DB >> 9808741

Identification of the binding and inhibition sites in the calmodulin molecule for ophiobolin A by site-directed mutagenesis.

T Kong Au1, P Chow Leung.   

Abstract

Ophiobolin A, a fungal toxin that affects maize and rice, has previously been shown to inhibit calmodulin by reacting with the lysine (Lys) residues in the calmodulin. In the present study we mutated Lys-75, Lys-77, and Lys-148 in the calmodulin molecule by site-directed mutagenesis, either by deleting them or by changing them to glutamine or arginine. We found that each of these three Lys residues could bind one molecule of ophiobolin A. Normally, only Lys-75 and Lys-148 bind ophiobolin A. Lys-77 seemed to be blocked by the binding of ophiobolin A to Lys-75. Lys-75 is the primary binding site and is responsible for all of the inhibition of ophiobolin A. When Lys-75 was removed, Lys-77 could then react with ophiobolin A to produce inhibition. Lys-148 was shown to be a binding site but not an inhibition site. The Lys-75 mutants were partially resistant to ophiobolin A. When both Lys 75 and Lys-77 or all three Lys residues were mutated, the resulting calmodulins were very resistant to ophiobolin A. Furthermore, Lys residues added in positions 86 and/or 143 (which are highly conserved in plant calmodulins) did not react with ophiobolin A. None of the mutations seemed to affect the properties of calmodulin. These results show that ophiobolin A reacts quite specifically with calmodulin.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9808741      PMCID: PMC34807          DOI: 10.1104/pp.118.3.965

Source DB:  PubMed          Journal:  Plant Physiol        ISSN: 0032-0889            Impact factor:   8.340


  24 in total

1.  Preparation and assay of the Ca2+--dependent modulator protein.

Authors:  R K Sharma; J H Wang
Journal:  Adv Cyclic Nucleotide Res       Date:  1979

2.  A simple method for site-directed mutagenesis using the polymerase chain reaction.

Authors:  A Hemsley; N Arnheim; M D Toney; G Cortopassi; D J Galas
Journal:  Nucleic Acids Res       Date:  1989-08-25       Impact factor: 16.971

3.  Cyclic 3',5'-nucleotide phosphodiesterase. Evidence for and properties of a protein activator.

Authors:  W Y Cheung
Journal:  J Biol Chem       Date:  1971-05-10       Impact factor: 5.157

4.  Structure of calmodulin refined at 2.2 A resolution.

Authors:  Y S Babu; C E Bugg; W J Cook
Journal:  J Mol Biol       Date:  1988-11-05       Impact factor: 5.469

5.  Assay of calmodulin by Ca2+-dependent phosphodiesterase.

Authors:  R W Wallace; E A Tallant; W Y Cheung
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

6.  Chemical synthesis and expression of a calmodulin gene designed for site-specific mutagenesis.

Authors:  D M Roberts; R Crea; M Malecha; G Alvarado-Urbina; R H Chiarello; D M Watterson
Journal:  Biochemistry       Date:  1985-09-10       Impact factor: 3.162

7.  Role of calmodulin inhibition in the mode of action of ophiobolin a.

Authors:  P C Leung; W A Taylor; J H Wang; C L Tipton
Journal:  Plant Physiol       Date:  1985-02       Impact factor: 8.340

8.  Effects of ophiobolin a on ion leakage and hexose uptake by maize roots.

Authors:  C L Tipton; P V Paulsen; R E Betts
Journal:  Plant Physiol       Date:  1977-05       Impact factor: 8.340

9.  Ophiobolin A. A natural product inhibitor of calmodulin.

Authors:  P C Leung; W A Taylor; J H Wang; C L Tipton
Journal:  J Biol Chem       Date:  1984-03-10       Impact factor: 5.157

10.  Calcium ion dependent covalent modification of calmodulin with norchlorpromazine isothiocyanate.

Authors:  D L Newton; T R Burke; K C Rice; C B Klee
Journal:  Biochemistry       Date:  1983-11-22       Impact factor: 3.162

View more
  9 in total

Review 1.  Natural compounds as next-generation herbicides.

Authors:  Franck E Dayan; Stephen O Duke
Journal:  Plant Physiol       Date:  2014-04-30       Impact factor: 8.340

2.  Bridging the gap between natural product synthesis and drug discovery.

Authors:  Nathanyal J Truax; Daniel Romo
Journal:  Nat Prod Rep       Date:  2020-10-26       Impact factor: 13.423

3.  Potential of phenothiazines to synergistically block calmodulin and reactivate PP2A in cancer cells.

Authors:  Ganesh Babu Manoharan; Sunday Okutachi; Daniel Abankwa
Journal:  PLoS One       Date:  2022-05-26       Impact factor: 3.752

4.  Ophiobolin A from Bipolaris oryzae perturbs motility and membrane integrities of porcine sperm and induces cell death on mammalian somatic cell lines.

Authors:  Ottó Bencsik; Tamás Papp; Máté Berta; Annamária Zana; Péter Forgó; György Dombi; Maria A Andersson; Mirja Salkinoja-Salonen; Csaba Vágvölgyi; András Szekeres
Journal:  Toxins (Basel)       Date:  2014-09-23       Impact factor: 4.546

Review 5.  The Biological Activities of Sesterterpenoid-Type Ophiobolins.

Authors:  Wei Tian; Zixin Deng; Kui Hong
Journal:  Mar Drugs       Date:  2017-07-18       Impact factor: 5.118

6.  Ophiobolin A, a sesterpenoid fungal phytotoxin, displays different mechanisms of cell death in mammalian cells depending upon the cancer cell origin.

Authors:  Rachel Morrison; Tiffany Lodge; Antonio Evidente; Robert Kiss; Helen Townley
Journal:  Int J Oncol       Date:  2017-01-19       Impact factor: 5.650

Review 7.  Pharmacological Strategies for Manipulating Plant Ca2+ Signalling.

Authors:  Kjell De Vriese; Alex Costa; Tom Beeckman; Steffen Vanneste
Journal:  Int J Mol Sci       Date:  2018-05-18       Impact factor: 5.923

8.  A Covalent Calmodulin Inhibitor as a Tool to Study Cellular Mechanisms of K-Ras-Driven Stemness.

Authors:  Sunday Okutachi; Ganesh Babu Manoharan; Alexandros Kiriazis; Christina Laurini; Marie Catillon; Frank McCormick; Jari Yli-Kauhaluoma; Daniel Abankwa
Journal:  Front Cell Dev Biol       Date:  2021-07-08

9.  Cancer stem cell drugs target K-ras signaling in a stemness context.

Authors:  A K Najumudeen; A Jaiswal; B Lectez; C Oetken-Lindholm; C Guzmán; E Siljamäki; I M D Posada; E Lacey; T Aittokallio; D Abankwa
Journal:  Oncogene       Date:  2016-03-14       Impact factor: 9.867

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.